相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis
Marc Corbera-Bellalta et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
CHARLSON COMORBIDITY INDEX (CCI) IN RHEUMATOID ARTHRITIS: CLASSIFICATION AND CORRELATIONS
C. Flourou et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis
Mehrdad Maz et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Sebastian Unizony et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study
Francesco Muratore et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Distinct macrophage phenotypes skewed by local granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis
William F. Jiemy et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
GM-CSFR PATHWAY IS IMPLICATED IN PATHOGENIC INFLAMMATORY MECHANISMS IN GIANT CELL ARTERITIS
M. C. Cid et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab
John H. Stone et al.
ARTHRITIS & RHEUMATOLOGY (2019)
GM-CSF PATHWAY SIGNATURE IDENTIFIED IN TEMPORAL ARTERY BIOPSIES OF PATIENTS WITH GIANT CELL ARTERITIS
Maria C. Cid et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
Michael E. Weinblatt et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Pathogenesis of giant-cell arteritis: how targeted therapies are influencing our understanding of the mechanisms involved
Nekane Terrades-Garcia et al.
RHEUMATOLOGY (2018)
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody Long-Term Safety and Efficacy in Patients With Rheumatoid Arthritis
Gerd R. Burmester et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities
Christian Dejaco et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Trial of Tocilizumab in Giant-Cell Arteritis
J. H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Jessica C. Wilson et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis
Carol A. Langford et al.
ARTHRITIS & RHEUMATOLOGY (2017)
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Targeting GM-CSF in inflammatory diseases
Ian P. Wicks et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study
Cristian Labarca et al.
RHEUMATOLOGY (2016)
Giant Cell Arteritis
Gary S. Hoffman
ANNALS OF INTERNAL MEDICINE (2016)
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study
Tanaz A. Kermani et al.
JOURNAL OF RHEUMATOLOGY (2015)
Relapses in Patients With Giant Cell Arteritis Prevalence, Characteristics, and Associated Clinical Findings in a Longitudinally Followed Cohort of 106 Patients
Marco A. Alba et al.
MEDICINE (2014)
Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica
S. Unizony et al.
ARTHRITIS CARE & RESEARCH (2012)
Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages
Bruce C. Trapnell et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Adjunctive methotrexate for treatment of giant cell arteritis -: An individual patient data meta-analysis
Alfred D. Mahr et al.
ARTHRITIS AND RHEUMATISM (2007)
Pulmonary alveolar proteinosis
BC Trapnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
A Proven et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
GS Hoffman et al.
ARTHRITIS AND RHEUMATISM (2002)
分享论文
